Cure Today31 分钟
Breaking Down Cancer Therapies Approved by the FDA in January 2025
Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...
Salarius resumes trial for MDS and CMML treatment
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) has announced the resumption of patient enrollment in a Phase 1/2 clinical trial evaluating seclidemstat combined with azacitidine for myelodysplastic ...
Cure Today4 天
A Phase 1 Trial of Iadademstat Plus Vidaza Has Dosed a Patient With MDS
The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...
VA adds several cancers as presumptive for service connection
On January 8th, 2025, the Department of Veterans Affairs announced that it is making acute and chronic leukemias, multiple ...
The American Journal of Managed Care11 天
Treosulfan Regimen Approved for Allo-HSCT Conditioning in AML/MDS
The FDA approved treosulfan in combination with fludarabine as preparation for allogeneic hematopoietic stem cell ...
ORYZON announces first patient dosed in an Investigator-initiated Phase I study of ...
Exploring the combination with azacitidineStudy led by Medical College of Wisconsin MADRID and CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) ...
Faron completes enrollment for BEXMAB Phase II MDS study
TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company, has announced the identification of the final patient for its BEXMAB Phase II ...
Targeted Oncology10 天
FDA Greenlights Treosulfan/Fludarabine Combo for AlloHSCT in AML and MDS
The combination of treosulfan and fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation ...